Biostatistician I (NCI)

This job is no longer active. View similar jobs.

POST DATE 9/16/2016
END DATE 11/12/2016

Leidos Biomedical Research, Inc. Rockville, MD

Company
Leidos Biomedical Research, Inc.
Job Classification
Full Time
Company Ref #
360931
AJE Ref #
576197384
Location
Rockville, MD
Experience
Entry Level (0 - 2 years)
Job Type
Regular

JOB DESCRIPTION

APPLY
COMPANY INFORMATION
Leidos Biomedical Research, Inc. (LBRI), a wholly owned subsidiary of Leidos, operates the Frederick National Laboratory for Cancer Research (FNLCR). FNLCR is a Federally Funded Research and Development Center (FFRDC) sponsored by the National Cancer Institute (NCI). It is the only FFRDC dedicated to biomedical research. Through its status as an FFRDC, FNLCR provides NCI and others with a unique national resource to accelerate the development and delivery of effective preventive, diagnostic, and therapeutic products for cancer and AIDS.

The breadth of FNLCR s activities spans the research and development spectrum, including investigator-initiated, hypothesis-driven research into cancer and AIDS; advanced technology programs focused on genetics and genomics, proteins and proteomics, imaging, nanotechnology, bioinformatics, and laboratory animal sciences; clinical operations in support of NCI and National Institute of Allergy and Infectious Diseases (NIAID)-sponsored clinical trials, as well as NCI drug discovery and development efforts; and management and operations of biopharmaceutical development and manufacturing programs under current Good Manufacturing Practice conditions for NCI and NIAID. Administrative, procurement, financial, safety, and facilities support is provided to these R&D activities through state-of-the-art business processes. LBRI has approximately 1,900 employees and manages an annual operating budget of approximately $450M.

For more information about Leidos Biomedical Research Inc., please visit our webpage at www.leidosbiomed.com.

PROGRAM DESCRIPTION
Within the Leidos Biomedical Research Inc. s Clinical Research Directorate, the Clinical Monitoring Research Program (CMRP) provides high-quality comprehensive and strategic operational support to the high-profile domestic and international clinical research initiatives of the National Cancer Institute (NCI), National Institute of Allergy and Infectious Diseases (NIAID), Clinical Center (CC), National Institute of Heart, Lung and Blood Institute (NHLBI), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Center for Advancing Translational Sciences (NCATS), National Institute of Neurological Disorders and Stroke (NINDS), and the National Institute of Mental Health (NIMH). Since its inception in 2001, CMRP s ability to provide rapid responses, high-quality solutions, and to recruit and retain experts with a variety of backgrounds to meet the growing research portfolios of NCI, NIAID, CC, NHLBI, NIAMS, NCATS, NINDS, and NIMH has led to the considerable expansion of the program and its repertoire of support services. CMRP s support services are strategically aligned with the program s mission to provide comprehensive, dedicated support to assist National Institutes of Health researchers in providing the highest quality of clinical research in compliance with applicable regulations and guidelines, maintaining data integrity, and protecting human subjects. For the scientific advancement of clinical research, CMRP services include comprehensive clinical trials, regulatory, pharmacovigilance, protocol navigation and development, and programmatic and project management support for facilitating the conduct of 400+ Phase I, II, and III domestic and international trials on a yearly basis. These trials investigate the prevention, diagnosis, treatment of, and therapies for cancer, influenza, HIV, and other infectious diseases and viruses such as hepatitis C, tuberculosis, malaria, and Ebola virus; heart, lung, and blood diseases and conditions; parasitic infections; rheumatic and inflammatory diseases; and rare and neglected diseases. CMRP s collaborative approach to clinical research and the expertise and dedication of staff to the continuation and success of the program s mission has contributed to improving the overall standards of public health on a global scale.

JOB DESCRIPTION
The Clinical Monitoring Research Program (CMRP) provides mathematical biostatistical support to the National Institute of Allergy and Infectious Diseases (NIAID) Biostatistics Research Branch (BRB) within the Division of Clinical Research (DCR).

The Biostatistician I: 1) performs statistical analyses on data related to the research, experimentation, diagnosis, treatment, prevention and cure of human disease, 2) supports that effort by performing programming and statistical analysis on a broad range of clinical and laboratory studies and creating databases to produce analysis data sets for assigned projects, 3) maintains expertise in state-of-the-art data manipulation and statistical analyses, 4) consults with investigators on design and analysis of clinical and observational studies using knowledge of statistical methods, 5) identifies appropriate methods to be used for processing and analyzing data that varies from project to project, 6) identifies programming requirements and assists investigators/information technology in the development of specialized programs to resolve problems related to statistics analysis, 7) performs database management support by merging data from single or multiple sources to produce analysis data sets for assigned projects, 8) provides programming support including writing code for specialized programs, searching the Internet for information needed for the project, producing graphics and tables and other related tasks, 9) interacts with clinical and laboratory investigators in processing data and conducting statistical analyses, 10) assures system and program documentation for assigned projects is complete and accurate, and 11) provides support for the development and analysis of novel high dimensional immune assay data collected through various Phase I drug therapy/vaccine studies conducted within the clinical laboratories.